Vertex Receives Two EU Approvals for KALYDECO for Cystic Fibrosis By: Benzinga via Benzinga November 18, 2015 at 04:19 AM EST Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Commission has approved ... Read More >> Related Stocks: Vertex Pharmaceuticals